IBDEI1TX.m

IBDEI1TX ; ; 04-FEB-2020

 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020

 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y

Q Q

 ;;^UTILITY(U,$J,358.3,29227,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,29227,1,3,0)

 ;;=3^Medication-Induced Parkinsonism,Other

 ;;^UTILITY(U,$J,358.3,29227,1,4,0)

 ;;=4^G21.19

 ;;^UTILITY(U,$J,358.3,29227,2)

 ;;=^5003773

 ;;^UTILITY(U,$J,358.3,29228,0)

 ;;=G21.11^^118^1471^13

 ;;^UTILITY(U,$J,358.3,29228,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,29228,1,3,0)

 ;;=3^Neuroleptic-Induced Parkinsonism

 ;;^UTILITY(U,$J,358.3,29228,1,4,0)

 ;;=4^G21.11

 ;;^UTILITY(U,$J,358.3,29228,2)

 ;;=^5003772

 ;;^UTILITY(U,$J,358.3,29229,0)

 ;;=G24.01^^118^1471^15

 ;;^UTILITY(U,$J,358.3,29229,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,29229,1,3,0)

 ;;=3^Tardive Dyskinesia

 ;;^UTILITY(U,$J,358.3,29229,1,4,0)

 ;;=4^G24.01

 ;;^UTILITY(U,$J,358.3,29229,2)

 ;;=^5003784

 ;;^UTILITY(U,$J,358.3,29230,0)

 ;;=G24.09^^118^1471^16

 ;;^UTILITY(U,$J,358.3,29230,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,29230,1,3,0)

 ;;=3^Tardive Dystonia

 ;;^UTILITY(U,$J,358.3,29230,1,4,0)

 ;;=4^G24.09

 ;;^UTILITY(U,$J,358.3,29230,2)

 ;;=^5003786

 ;;^UTILITY(U,$J,358.3,29231,0)

 ;;=G25.1^^118^1471^11

 ;;^UTILITY(U,$J,358.3,29231,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,29231,1,3,0)

 ;;=3^Medication-Induced Postural Tremor

 ;;^UTILITY(U,$J,358.3,29231,1,4,0)

 ;;=4^G25.1

 ;;^UTILITY(U,$J,358.3,29231,2)

 ;;=^5003792

 ;;^UTILITY(U,$J,358.3,29232,0)

 ;;=G25.71^^118^1471^14

 ;;^UTILITY(U,$J,358.3,29232,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,29232,1,3,0)

 ;;=3^Tardive Akathisia

 ;;^UTILITY(U,$J,358.3,29232,1,4,0)

 ;;=4^G25.71

 ;;^UTILITY(U,$J,358.3,29232,2)

 ;;=^5003799

 ;;^UTILITY(U,$J,358.3,29233,0)

 ;;=G25.79^^118^1471^9

 ;;^UTILITY(U,$J,358.3,29233,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,29233,1,3,0)

 ;;=3^Medication-Induced Movement Disorder,Other

 ;;^UTILITY(U,$J,358.3,29233,1,4,0)

 ;;=4^G25.79

 ;;^UTILITY(U,$J,358.3,29233,2)

 ;;=^5003800

 ;;^UTILITY(U,$J,358.3,29234,0)

 ;;=T43.205A^^118^1471^4

 ;;^UTILITY(U,$J,358.3,29234,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,29234,1,3,0)

 ;;=3^Antidepressant Discontinuation Syndrome,Init Encntr

 ;;^UTILITY(U,$J,358.3,29234,1,4,0)

 ;;=4^T43.205A

 ;;^UTILITY(U,$J,358.3,29234,2)

 ;;=^5050540

 ;;^UTILITY(U,$J,358.3,29235,0)

 ;;=T43.205D^^118^1471^5

 ;;^UTILITY(U,$J,358.3,29235,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,29235,1,3,0)

 ;;=3^Antidepressant Discontinuation Syndrome,Subseq Encntr

 ;;^UTILITY(U,$J,358.3,29235,1,4,0)

 ;;=4^T43.205D

 ;;^UTILITY(U,$J,358.3,29235,2)

 ;;=^5050541

 ;;^UTILITY(U,$J,358.3,29236,0)

 ;;=T43.205S^^118^1471^6

 ;;^UTILITY(U,$J,358.3,29236,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,29236,1,3,0)

 ;;=3^Antidepressant Discontinuation Syndrome,Sequela

 ;;^UTILITY(U,$J,358.3,29236,1,4,0)

 ;;=4^T43.205S

 ;;^UTILITY(U,$J,358.3,29236,2)

 ;;=^5050542

 ;;^UTILITY(U,$J,358.3,29237,0)

 ;;=G25.71^^118^1471^7

 ;;^UTILITY(U,$J,358.3,29237,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,29237,1,3,0)

 ;;=3^Medication-Induced Acute Akathisia

 ;;^UTILITY(U,$J,358.3,29237,1,4,0)

 ;;=4^G25.71

 ;;^UTILITY(U,$J,358.3,29237,2)

 ;;=^5003799

 ;;^UTILITY(U,$J,358.3,29238,0)

 ;;=G24.02^^118^1471^8

 ;;^UTILITY(U,$J,358.3,29238,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,29238,1,3,0)

 ;;=3^Medication-Induced Acute Dystonia

 ;;^UTILITY(U,$J,358.3,29238,1,4,0)

 ;;=4^G24.02

 ;;^UTILITY(U,$J,358.3,29238,2)

 ;;=^5003785

 ;;^UTILITY(U,$J,358.3,29239,0)

 ;;=G21.0^^118^1471^12

 ;;^UTILITY(U,$J,358.3,29239,1,0)

 ;;=^358.31IA^4^2

--- Routine Detail   --- with STRUCTURED ROUTINE LISTING ---IBDEI1TX   3787     printed  Mar 13, 2025@21:20:29                                                                                                                                                                                                    Page 2

IBDEI1TX  ; ; 04-FEB-2020

 +1       ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020

 +2        if 'DIFQR(358.3)

               QUIT 

           FOR I=1:2

               SET X=$TEXT(Q+I)

               if X=""

                   QUIT 

               SET Y=$EXTRACT($TEXT(Q+I+1),4,999)

               SET X=$EXTRACT(X,4,999)

               if $ASCII(Y)=126

                   SET I=I+1

                   SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)

               if $ASCII(Y)=61

                   SET Y=$EXTRACT(Y,2,999)

               XECUTE NO

              IF '$TEST

                   SET @X=Y

Q          QUIT 

 +1       ;;^UTILITY(U,$J,358.3,29227,1,0)

 +2       ;;=^358.31IA^4^2

 +3       ;;^UTILITY(U,$J,358.3,29227,1,3,0)

 +4       ;;=3^Medication-Induced Parkinsonism,Other

 +5       ;;^UTILITY(U,$J,358.3,29227,1,4,0)

 +6       ;;=4^G21.19

 +7       ;;^UTILITY(U,$J,358.3,29227,2)

 +8       ;;=^5003773

 +9       ;;^UTILITY(U,$J,358.3,29228,0)

 +10      ;;=G21.11^^118^1471^13

 +11      ;;^UTILITY(U,$J,358.3,29228,1,0)

 +12      ;;=^358.31IA^4^2

 +13      ;;^UTILITY(U,$J,358.3,29228,1,3,0)

 +14      ;;=3^Neuroleptic-Induced Parkinsonism

 +15      ;;^UTILITY(U,$J,358.3,29228,1,4,0)

 +16      ;;=4^G21.11

 +17      ;;^UTILITY(U,$J,358.3,29228,2)

 +18      ;;=^5003772

 +19      ;;^UTILITY(U,$J,358.3,29229,0)

 +20      ;;=G24.01^^118^1471^15

 +21      ;;^UTILITY(U,$J,358.3,29229,1,0)

 +22      ;;=^358.31IA^4^2

 +23      ;;^UTILITY(U,$J,358.3,29229,1,3,0)

 +24      ;;=3^Tardive Dyskinesia

 +25      ;;^UTILITY(U,$J,358.3,29229,1,4,0)

 +26      ;;=4^G24.01

 +27      ;;^UTILITY(U,$J,358.3,29229,2)

 +28      ;;=^5003784

 +29      ;;^UTILITY(U,$J,358.3,29230,0)

 +30      ;;=G24.09^^118^1471^16

 +31      ;;^UTILITY(U,$J,358.3,29230,1,0)

 +32      ;;=^358.31IA^4^2

 +33      ;;^UTILITY(U,$J,358.3,29230,1,3,0)

 +34      ;;=3^Tardive Dystonia

 +35      ;;^UTILITY(U,$J,358.3,29230,1,4,0)

 +36      ;;=4^G24.09

 +37      ;;^UTILITY(U,$J,358.3,29230,2)

 +38      ;;=^5003786

 +39      ;;^UTILITY(U,$J,358.3,29231,0)

 +40      ;;=G25.1^^118^1471^11

 +41      ;;^UTILITY(U,$J,358.3,29231,1,0)

 +42      ;;=^358.31IA^4^2

 +43      ;;^UTILITY(U,$J,358.3,29231,1,3,0)

 +44      ;;=3^Medication-Induced Postural Tremor

 +45      ;;^UTILITY(U,$J,358.3,29231,1,4,0)

 +46      ;;=4^G25.1

 +47      ;;^UTILITY(U,$J,358.3,29231,2)

 +48      ;;=^5003792

 +49      ;;^UTILITY(U,$J,358.3,29232,0)

 +50      ;;=G25.71^^118^1471^14

 +51      ;;^UTILITY(U,$J,358.3,29232,1,0)

 +52      ;;=^358.31IA^4^2

 +53      ;;^UTILITY(U,$J,358.3,29232,1,3,0)

 +54      ;;=3^Tardive Akathisia

 +55      ;;^UTILITY(U,$J,358.3,29232,1,4,0)

 +56      ;;=4^G25.71

 +57      ;;^UTILITY(U,$J,358.3,29232,2)

 +58      ;;=^5003799

 +59      ;;^UTILITY(U,$J,358.3,29233,0)

 +60      ;;=G25.79^^118^1471^9

 +61      ;;^UTILITY(U,$J,358.3,29233,1,0)

 +62      ;;=^358.31IA^4^2

 +63      ;;^UTILITY(U,$J,358.3,29233,1,3,0)

 +64      ;;=3^Medication-Induced Movement Disorder,Other

 +65      ;;^UTILITY(U,$J,358.3,29233,1,4,0)

 +66      ;;=4^G25.79

 +67      ;;^UTILITY(U,$J,358.3,29233,2)

 +68      ;;=^5003800

 +69      ;;^UTILITY(U,$J,358.3,29234,0)

 +70      ;;=T43.205A^^118^1471^4

 +71      ;;^UTILITY(U,$J,358.3,29234,1,0)

 +72      ;;=^358.31IA^4^2

 +73      ;;^UTILITY(U,$J,358.3,29234,1,3,0)

 +74      ;;=3^Antidepressant Discontinuation Syndrome,Init Encntr

 +75      ;;^UTILITY(U,$J,358.3,29234,1,4,0)

 +76      ;;=4^T43.205A

 +77      ;;^UTILITY(U,$J,358.3,29234,2)

 +78      ;;=^5050540

 +79      ;;^UTILITY(U,$J,358.3,29235,0)

 +80      ;;=T43.205D^^118^1471^5

 +81      ;;^UTILITY(U,$J,358.3,29235,1,0)

 +82      ;;=^358.31IA^4^2

 +83      ;;^UTILITY(U,$J,358.3,29235,1,3,0)

 +84      ;;=3^Antidepressant Discontinuation Syndrome,Subseq Encntr

 +85      ;;^UTILITY(U,$J,358.3,29235,1,4,0)

 +86      ;;=4^T43.205D

 +87      ;;^UTILITY(U,$J,358.3,29235,2)

 +88      ;;=^5050541

 +89      ;;^UTILITY(U,$J,358.3,29236,0)

 +90      ;;=T43.205S^^118^1471^6

 +91      ;;^UTILITY(U,$J,358.3,29236,1,0)

 +92      ;;=^358.31IA^4^2

 +93      ;;^UTILITY(U,$J,358.3,29236,1,3,0)

 +94      ;;=3^Antidepressant Discontinuation Syndrome,Sequela

 +95      ;;^UTILITY(U,$J,358.3,29236,1,4,0)

 +96      ;;=4^T43.205S

 +97      ;;^UTILITY(U,$J,358.3,29236,2)

 +98      ;;=^5050542

 +99      ;;^UTILITY(U,$J,358.3,29237,0)

 +100     ;;=G25.71^^118^1471^7

 +101     ;;^UTILITY(U,$J,358.3,29237,1,0)

 +102     ;;=^358.31IA^4^2

 +103     ;;^UTILITY(U,$J,358.3,29237,1,3,0)

 +104     ;;=3^Medication-Induced Acute Akathisia

 +105     ;;^UTILITY(U,$J,358.3,29237,1,4,0)

 +106     ;;=4^G25.71

 +107     ;;^UTILITY(U,$J,358.3,29237,2)

 +108     ;;=^5003799

 +109     ;;^UTILITY(U,$J,358.3,29238,0)

 +110     ;;=G24.02^^118^1471^8

 +111     ;;^UTILITY(U,$J,358.3,29238,1,0)

 +112     ;;=^358.31IA^4^2

 +113     ;;^UTILITY(U,$J,358.3,29238,1,3,0)

 +114     ;;=3^Medication-Induced Acute Dystonia

 +115     ;;^UTILITY(U,$J,358.3,29238,1,4,0)

 +116     ;;=4^G24.02

 +117     ;;^UTILITY(U,$J,358.3,29238,2)

 +118     ;;=^5003785

 +119     ;;^UTILITY(U,$J,358.3,29239,0)

 +120     ;;=G21.0^^118^1471^12

 +121     ;;^UTILITY(U,$J,358.3,29239,1,0)

 +122     ;;=^358.31IA^4^2